| Parkinson’s disease in women and men: what’s the difference? S Cerri, L Mus, F Blandini Journal of Parkinson's disease 9 (3), 501-515, 2019 | 779 | 2019 |
| A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease G Ambrosi, S Cerri, F Blandini Journal of neural transmission 121, 849-859, 2014 | 239 | 2014 |
| Role of autophagy in Parkinson’s disease S Cerri, F Blandini Current medicinal chemistry 26 (20), 3702-3718, 2019 | 130 | 2019 |
| Inefficient DNA repair is an aging-related modifier of Parkinson’s disease S Sepe, C Milanese, S Gabriels, KWJ Derks, C Payan-Gomez, ... Cell reports 15 (9), 1866-1875, 2016 | 130 | 2016 |
| Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease C Milanese, S Cerri, A Ulusoy, SV Gornati, A Plat, S Gabriels, F Blandini, ... Cell death & disease 9 (8), 818, 2018 | 123 | 2018 |
| Glucocerebrosidase mutations and synucleinopathies: toward a model of precision medicine F Blandini, R Cilia, S Cerri, G Pezzoli, AHV Schapira, S Mullin, ... Movement Disorders 34 (1), 9-21, 2019 | 103 | 2019 |
| Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration C Pellegrini, M Fornai, R Colucci, E Tirotta, F Blandini, G Levandis, ... Journal of neuroinflammation 13, 1-13, 2016 | 97 | 2016 |
| The exosomal/total α-synuclein ratio in plasma is associated with glucocerebrosidase activity and correlates with measures of disease severity in PD patients S Cerri, C Ghezzi, M Sampieri, F Siani, M Avenali, G Dornini, R Zangaglia, ... Frontiers in cellular neuroscience 12, 125, 2018 | 91 | 2018 |
| Glucocerebrosidase defects as a major risk factor for Parkinson’s disease M Avenali, F Blandini, S Cerri Frontiers in aging neuroscience 12, 97, 2020 | 87 | 2020 |
| Activation of the CREB/c-Fos Pathway during Long-Term Synaptic Plasticity in the Cerebellum Granular Layer D Gandolfi, S Cerri, J Mapelli, M Polimeni, S Tritto, MT Fuzzati-Armentero, ... Frontiers in cellular neuroscience 11, 184, 2017 | 82 | 2017 |
| Peripheral-central neuroimmune crosstalk in Parkinson's disease: what do patients and animal models tell us? MT Fuzzati-Armentero, S Cerri, F Blandini Frontiers in neurology 10, 232, 2019 | 75 | 2019 |
| Intracarotid infusion of mesenchymal stem cells in an animal model of Parkinson's disease, focusing on cell distribution and neuroprotective and behavioral effects S Cerri, R Greco, G Levandis, C Ghezzi, AS Mangione, ... Stem Cells Translational Medicine 4 (9), 1073-1085, 2015 | 70 | 2015 |
| Enteric dysfunctions in experimental Parkinson’s disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats M Fornai, C Pellegrini, L Antonioli, C Segnani, C Ippolito, E Barocelli, ... Journal of Pharmacology and Experimental Therapeutics 356 (2), 434-444, 2016 | 66 | 2016 |
| Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation C Galvagnion, FR Marlet, S Cerri, AHV Schapira, F Blandini, DA Di Monte Brain 145 (3), 1038-1051, 2022 | 62 | 2022 |
| Neuroprotective and symptomatic effects of cannabidiol in an animal model of Parkinson’s disease C Giuliano, M Francavilla, G Ongari, A Petese, C Ghezzi, N Rossini, ... International Journal of Molecular Sciences 22 (16), 8920, 2021 | 55 | 2021 |
| The developmental neurotoxicity study of platinum compounds. Effects of cisplatin versus a novel Pt (II) complex on rat cerebellum S Cerri, VM Piccolini, G Santin, MG Bottone, SA De Pascali, D Migoni, ... Neurotoxicology and teratology 33 (2), 273-281, 2011 | 52 | 2011 |
| Noninvasive near-infrared live imaging of human adult mesenchymal stem cells transplanted in a rodent model of Parkinson’s disease P Bossolasco, L Cova, G Levandis, V Diana, S Cerri, GL Deliliers, E Polli, ... International Journal of Nanomedicine, 435-447, 2012 | 45 | 2012 |
| Neuroprotective Potential of Adenosine A2A and Cannabinoid CB1 Receptor Antagonists in an Animal Model of Parkinson Disease S Cerri, G Levandis, G Ambrosi, E Montepeloso, GF Antoninetti, R Franco, ... Journal of Neuropathology & Experimental Neurology 73 (5), 414-424, 2014 | 43 | 2014 |
| Complex changes in the innate and adaptive immunity accompany progressive degeneration of the nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine in … G Ambrosi, N Kustrimovic, F Siani, E Rasini, S Cerri, C Ghezzi, G Dicorato, ... Neurotoxicity research 32, 71-81, 2017 | 39 | 2017 |
| Potential therapeutic effects of polyphenols in Parkinson’s disease: in vivo: and: in vitro: pre-clinical studies C Giuliano, S Cerri, F Blandini Neural Regeneration Research 16 (2), 234-241, 2021 | 38 | 2021 |
